These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 21276207)

  • 21. Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease.
    Wieland AC; Quallick M; Truesdale A; Mettler P; Bambha KM
    Dig Dis Sci; 2013 Oct; 58(10):2809-16. PubMed ID: 23843097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases].
    Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):161-3. PubMed ID: 16700132
    [No Abstract]   [Full Text] [Related]  

  • 23. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases.
    Zeng MD; Fan JG; Lu LG; Li YM; Chen CW; Wang BY; Mao YM;
    J Dig Dis; 2008 May; 9(2):108-12. PubMed ID: 18419645
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty liver: yet another silent killer.
    Javed M
    J Ayub Med Coll Abbottabad; 2014; 26(1):1-2. PubMed ID: 25358204
    [No Abstract]   [Full Text] [Related]  

  • 26. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground.
    Chitturi S; Wong VW; Farrell G
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():163-72. PubMed ID: 21199528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ; ; ;
    Am J Gastroenterol; 2012 Jun; 107(6):811-26. PubMed ID: 22641309
    [No Abstract]   [Full Text] [Related]  

  • 28. [Brief introduction of American practice guideline for the diagnosis and management of non-alcoholic fatty liver disease].
    Ding XD; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):430-1. PubMed ID: 23230594
    [No Abstract]   [Full Text] [Related]  

  • 29. [Topics update in NAFLD: from bench side to clinics].
    Ikejima K; Watanabe S
    Nihon Shokakibyo Gakkai Zasshi; 2014 Jan; 111(1):4-13. PubMed ID: 24390254
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
    Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
    World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between UCP3 gene polymorphisms and nonalcoholic fatty liver disease in Chinese children.
    Xu YP; Liang L; Wang CL; Fu JF; Liu PN; Lv LQ; Zhu YM
    World J Gastroenterol; 2013 Sep; 19(35):5897-903. PubMed ID: 24124336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcoholic and nonalcoholic forms of fatty liver disease.
    Forgione A; Miele L; Cefalo C; Gasbarrini G; Grieco A
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):83-100. PubMed ID: 17415346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fatty liver: frequent and not completely harmless].
    Lang C; Georgi A; Gubler C
    Praxis (Bern 1994); 2013 Sep; 102(18):1089-101. PubMed ID: 24005067
    [No Abstract]   [Full Text] [Related]  

  • 34. Mitochondrial polymorphism 12361A>G is associated with nonalcoholic fatty liver disease.
    Lu MY; Huang JF; Liao YC; Bai RK; Trieu RB; Chuang WL; Yu ML; Juo SH; Wong LJ
    Transl Res; 2012 Jan; 159(1):58-9. PubMed ID: 22153811
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetes and Fatty Liver.
    Stefan N; Roden M
    Exp Clin Endocrinol Diabetes; 2024 Mar; 132(3):136-141. PubMed ID: 38325402
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
    Rafiq N; Younossi ZM
    Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.
    Ong JP; Younossi ZM
    Clin Liver Dis; 2005 Nov; 9(4):617-34, vi. PubMed ID: 16207567
    [TBL] [Abstract][Full Text] [Related]  

  • 38.  Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD).
    Choudhary NS; Duseja A; Kalra N; Das A; Dhiman RK; Chawla YK
    Ann Hepatol; 2012; 11(4):478-86. PubMed ID: 22700629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Carbohydrate Rather Than Low Fat Is More Important in Dietary Management of Nonalcoholic Steatohepatitis.
    Lankarani KB; Alavian SM
    Gastroenterology; 2015 Dec; 149(7):1987-8. PubMed ID: 26515490
    [No Abstract]   [Full Text] [Related]  

  • 40. Are we ready for a new epidemic of under recognized liver disease in South Asia especially in Pakistan? Non alcoholic fatty liver disease.
    Parkash O; Hamid S
    J Pak Med Assoc; 2013 Jan; 63(1):95-9. PubMed ID: 23865141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.